Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48408
Campo DC Valoridioma
dc.contributor.authorLoro, J. F.en_US
dc.contributor.authorZhang, J.en_US
dc.contributor.authorPfaffendorf, M.en_US
dc.contributor.authorVan Zwieten, P. A.en_US
dc.date.accessioned2018-11-23T21:29:41Z-
dc.date.available2018-11-23T21:29:41Z-
dc.date.issued1998en_US
dc.identifier.issn0767-3981en_US
dc.identifier.urihttp://hdl.handle.net/10553/48408-
dc.description.abstractThe positive chronotropic effect of bradykinin was investigated in the pithed rat preparation. Cumulative treatment with bradykinin (0.20 nmol/kg-6.59 mu mol/kg, intravenous [iv]) caused a dose-dependent increase in heart rate (HR) by a maximum of 80 +/- 3.3 beats min(-1). In contrast, the active metabolite of bradykinin and selective bradykinin B-1-receptor agonist, [des-Arg(9)]-bradykinin did not influence the spontaneous frequency of beating. Propranolol alone reduced the bradykinin-induced increase in HR and a combination of propranolol with prazosin abolished the chronotropic effect of bradykinin. The selective bradykinin B-2 receptor antagonist, Hoe 140, dose-dependently shifted the dose-response curves of bradykinin to the right, whereas the bradykinin B1 receptor antagonist, des-Arg(10)-[Leu(9)]-kallidin proved ineffective. From our experiments it may be concluded that bradykinin induces tachycardia in the pithed rat primarily by stimulating the sympathetic ganglia leading to the release of noradrenaline, which subsequently activates cardiac beta(1)-adrenoceptors. The bradykinin-induced chronotropic effect is mediated by bradykinin B-2-receptors, whereas B-1-receptors appear not to be involved.en_US
dc.languageengen_US
dc.relation.ispartofFundamental and Clinical Pharmacologyen_US
dc.sourceFundamental and Clinical Pharmacology[ISSN 0767-3981],v. 12, p. 77-81en_US
dc.subject32 Ciencias médicasen_US
dc.subject3209 Farmacologíaen_US
dc.subject.otherGuinea-Pig Atriaen_US
dc.subject.otherAngiotensin-Iien_US
dc.subject.otherReceptoren_US
dc.subject.otherProstaglandinsen_US
dc.subject.otherB-1en_US
dc.titlePositive chronotropic activity of bradykinin in the pithed normotensive raten_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1111/j.1472-8206.1998.tb00927.xen_US
dc.identifier.scopus0031906746-
dc.identifier.isi000071848600010-
dc.contributor.authorscopusid6507389169-
dc.contributor.authorscopusid55870821500-
dc.contributor.authorscopusid7004720913-
dc.contributor.authorscopusid36041684500-
dc.contributor.authorscopusid36041684500-
dc.description.lastpage81en_US
dc.description.firstpage77en_US
dc.relation.volume12en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid3210878-
dc.contributor.daisngid14119464-
dc.contributor.daisngid94243-
dc.contributor.daisngid12073-
dc.description.numberofpages5en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Loro, JF-
dc.contributor.wosstandardWOS:Zhang, J-
dc.contributor.wosstandardWOS:Pfaffendorf, M-
dc.contributor.wosstandardWOS:van Zwieten, PA-
dc.date.coverdateEnero 1998en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr0,753-
dc.description.jcrqQ3-
dc.description.scieSCIE-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-0517-8209-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameLoro Ferrer, Juan Francisco-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

7
actualizado el 02-mar-2025

Citas de WEB OF SCIENCETM
Citations

7
actualizado el 02-mar-2025

Visitas

91
actualizado el 10-ago-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.